Nanologica Q4 2024: Initial comments - Redeye

Redeye's immediate take on Nanologica's year-end report is relatively undramatic. While sales and profitability were softer than we had estimated, the report signals improving production, which remains a key parameter for the company's outlook. We anticipate maintaining our fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/1073721/nanologica-q4-2024-initial-comments?utm_source=finwire&utm_medium=RSS